madopar 50mg/12.5mg capsules
roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 12.5mg ; 50mg
madopar 200mg/50mg capsules
roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 50mg ; 200mg
madopar 50mg/12.5mg dispersible tablets
roche products ltd - benserazide hydrochloride; levodopa - dispersible tablet - 12.5mg ; 50mg
madopar 100mg/25mg dispersible tablets
roche products ltd - benserazide hydrochloride; levodopa - dispersible tablet - 25mg ; 100mg
madopar roche 125 capsule
roche (malaysia) sdn. bhd. - benserazide hydrochloride; levodopa -
prolopa 250 200 mg - 50 mg tabl.
roche sa-nv - levodopa 200 mg; benserazidehydrochloride 57 mg - eq. benserazide 50 mg - tablet - 200 mg - 50 mg - levodopa 200 mg; benserazidehydrochloride 57 mg - levodopa and decarboxylase inhibitor
madopar tab (200+50)mg/tab
roche hellas a.e Αλαμάνας 4 & Δελφών,, 151 25 151 25, Μαρούσι 61 66 100 - levodopa; benserazide hydrochloride - tab (ΔΙΣΚΙΟ) - (200+50)mg/tab - levodopa 200mg; benserazide hydrochloride 58mg - levodopa and decarboxylase inhibitor
madopar 200 mg/50 mg hard capsules
roche products (ireland) ltd - levodopa; benserazide - capsule, hard - 200 mg/50 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor
madopar
roche products pty ltd - levodopa; benserazide hydrochloride; benserazide -
madopar tablet (200/50)
roche products pty ltd - benserazide hydrochloride, quantity: 57 mg (equivalent: benserazide, qty 50 mg); levodopa, quantity: 200 mg - tablet, uncoated - excipient ingredients: iron oxide red; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; mannitol; pregelatinised maize starch; docusate sodium; ethylcellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.